Cite
HARVARD Citation
Sarafidis, P. et al. (2019). SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA. Nephrology dialysis transplantation. 34 (2), pp. 208-230. [Online].